Last week London-based mobile diabetes management company, Cellnovo announced a whopping $48 million second round of funding. While the company has been long known as the developer of a wireless-enabled insulin pump, in recent years it has stressed its software competency, and even made analagous comments between its offerings and Apple's iTunes Store.
This week Medcity News pointed its readers...
